Reuters: Pfizer agrees to $190 million settlement over generic Neurontin

NEW YORK (Reuters) - Pfizer Inc has agreed to pay $190 million to settle a class action lawsuit alleging the pharmaceutical company took steps to delay market entry of generic versions of its epilepsy drug Neurontin, according to court documents filed on Monday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/mx0BZsA5uao/story01.htm

Read More